The disease nucleotide decreased FLG expression (Supplementary Fig. 6f), indicating that FLG is a rs72696969 target gene and that the atopic dermatitis risk daSNV down-modulates expression of this differentiation gene essential for normal barrier function. The gene discussed is FLG; the disease is atopic eczema.